Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

117.78
Delayed Data
As of May 27
 +0.63 / +0.54%
Today’s Change
102.50
Today|||52-Week Range
190.13
-24.79%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close117.15
Today’s open116.98
Day’s range115.64 - 117.89
Volume406,275
Average volume (3 months)774,962
Market cap$5.2B
Dividend yield--
Data as of 05/27/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+7.37%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.76%
P/E ratio6.7
Price/Sales5.47
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.65+1.64%
OPKOPKO Health Inc-0.01-0.10%
ANACAnacor Pharmaceutica...-0.64-0.64%
GRFSGrifols SA+0.13+0.81%
Data as of 05/27/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$3.12
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers

Search for Jobs